| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/27/2011 | CN101194918B Technique for removing ginkgolic acid in folium ginkgo extract |
| 04/27/2011 | CN101176772B Pharmaceutical composition made of cattail pollen and safflower |
| 04/27/2011 | CN101113149B Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof |
| 04/27/2011 | CN101085297B Traditional Chinese medicine freeze dried injection for curing cerebral infarction and preparation method thereof |
| 04/27/2011 | CN101062094B Total salvianolic acids long-cycle liposomes and the preparing method thereof |
| 04/27/2011 | CN101049355B Composition of medication prepared from safflower and leaves of hawthorn |
| 04/27/2011 | CN101019645B Health food for remitting fatigue and raising hypoxia tolerance and its preparation method |
| 04/27/2011 | CN101006846B Anti-stress nutrition additives for poultry and its preparation method |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | US7932265 Solution formulations of sirolimus and its analogs for CAD treatment |
| 04/26/2011 | US7932259 Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group |
| 04/26/2011 | US7932253 Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 04/26/2011 | US7931022 Method and apparatus for dispensing inhalator medicament |
| 04/26/2011 | CA2543676C Tyrosinase activity inhibitor and ameliorant for facial blood flow |
| 04/26/2011 | CA2504873C Percutaneous absorption preparation containing 3-methyl-1-phenyl-2-pyrazolin-5-one |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2462416C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 04/26/2011 | CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2432438C Flexible microchip devices for ophthalmic and other applications |
| 04/26/2011 | CA2424565C Novel crystalline forms of a factor xa inhibitor |
| 04/26/2011 | CA2423628C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/26/2011 | CA2408838C Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/26/2011 | CA2400871C Novel malconic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/26/2011 | CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 04/26/2011 | CA2326141C Use of receptor of a ror family for screening substances useful for the treatment of atherosclerosis |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/26/2011 | CA2264012C Compositions and methods for polynucleotide delivery |
| 04/22/2011 | CA2684017A1 Ectonucleotidase pyrophosphate/phosphodiesterase-1 (enpp-1) as a target for the treatment of aortic valve stenosis and cardiovascular calcification |
| 04/21/2011 | WO2011047345A2 Methods of treating diseases of conditions using mesenchymal stem cells |
| 04/21/2011 | WO2011047309A2 Treatment of ischemic tissue |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047173A2 Pharmaceutical compositions for oral administration |
| 04/21/2011 | WO2011047040A2 Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011046757A2 Accelerating thrombus resolution through augmentation of p53 activity |
| 04/21/2011 | WO2011046569A1 Process for the preparation of f-series prostaglandins |
| 04/21/2011 | WO2011046392A2 Composition for improving blood circulation and alleviating cold hands and feet, containing fermented tea extract |
| 04/21/2011 | WO2011046200A1 Antiinflammatory agent comprising differentiation-inducing factor or analog thereof |
| 04/21/2011 | WO2011045081A1 Use of lactoferrin and lactoferrin-containing compositions |
| 04/21/2011 | WO2011044742A1 Medicaments for inhibiting thrombosis |
| 04/21/2011 | WO2011044636A1 Na-k pump modulation |
| 04/21/2011 | WO2011044628A1 Allergy treatment using acid treated aqueous whey protein extract |
| 04/21/2011 | WO2011023954A3 Polymorphic forms of manidipine |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2010144742A3 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 04/21/2011 | WO2010144678A3 Generation of vascularized human heart tissue and uses thereof |
| 04/21/2011 | WO2010144477A3 Sulfonylurea modulators of endothelin receptor |
| 04/21/2011 | WO2010141600A3 Improved method for synthesizing pirfenidone |
| 04/21/2011 | WO2010141494A3 Synthesis of ezetimibe |
| 04/21/2011 | WO2010138180A3 Compositions and methods for cardiac tissue repair |
| 04/21/2011 | WO2008090472A3 Tissue progenitor cells that overexpress erg |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092594 Use of nitrated lipids for treatment of lipid disorders and obesity, and lipid- and obesity-related conditions |
| 04/21/2011 | US20110092575 Sirna of human osteopontin |
| 04/21/2011 | US20110092563 Statin and omega-3 fatty acids for lipid therapy |
| 04/21/2011 | US20110092555 Thiazolidinedione compound |
| 04/21/2011 | US20110092552 Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids |
| 04/21/2011 | US20110092551 Dual-acting imidazole antihypertensive agents |
| 04/21/2011 | US20110092545 Compounds, Compositions and Methods for Stabilizing Transthyretin and Inhibiting Transthyretin Misfolding |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092519 5,7-disubstituted thiazolo[4,5-d]pyrimidines as chemokine inhibitors |
| 04/21/2011 | US20110092517 Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases |
| 04/21/2011 | US20110092516 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases |
| 04/21/2011 | US20110092512 New hsl inhibitors useful in the treatment of diabetes |
| 04/21/2011 | US20110092510 Dpp-iv inhibitors for use in the treatment of nafld |
| 04/21/2011 | US20110092506 Trisubstituted amine compound |
| 04/21/2011 | US20110092505 Organic compounds |
| 04/21/2011 | US20110092502 Diaminothiazoles useful as axl inhibitors |
| 04/21/2011 | US20110092492 Imidazo compounds |
| 04/21/2011 | US20110092490 Pyrimidines, triazines and their use as pharmaceutical agents |
| 04/21/2011 | US20110092484 Therapeutic or prophylactic agent for cerebral aneurysm |
| 04/21/2011 | US20110092478 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092469 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy |
| 04/21/2011 | US20110092468 Pharmaceutical Calcimimetics |
| 04/21/2011 | US20110092463 Combination for use in the treatment of inflammatory disorders |
| 04/21/2011 | US20110092456 Methods of increasing cAMP levels and uses thereof |
| 04/21/2011 | US20110092432 Vascular aging inhibitor and anti-aging formulation |
| 04/21/2011 | US20110092430 Method and compound for the treatment of valvular disease |
| 04/21/2011 | US20110092417 Leptin fusion proteins |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091585 Herbal compositions and methods for enhancing vital energy and athletic performance |
| 04/21/2011 | US20110091576 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells |
| 04/21/2011 | US20110091566 Controlled release pharmaceutical compositions |
| 04/21/2011 | US20110091561 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
| 04/21/2011 | US20110091543 Oral delivery of modified transferrin fusion proteins |
| 04/21/2011 | US20110091541 Preparation of formulations of angiotensin II at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 04/21/2011 | US20110091540 Polymeric compositions and their method of use in combination with active agents |
| 04/21/2011 | US20110091535 Solid pharmaceutical formulation |
| 04/21/2011 | US20110091534 Compositions comprising polymeric micelles for drug delivery |
| 04/21/2011 | US20110091527 Compositions and methods for reducing scar formation in wound healing |
| 04/21/2011 | US20110091515 Drug-eluting medical devices |
| 04/21/2011 | US20110091511 Transdermal delivery of drugs based on crystal size |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091485 Modulation of cell junctions |